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ABSTRACT 
Objective: The objective of the study is to evaluate the therapeutic effect of Centella asiatica leaves by assaying the activities of selective 
mitochondrial and cytosolic enzymes in the streptozotocin induced diabetic rats. 
Methods: The rats were divided into five groups of 6 rats in each group. The methanol extract of Centella asiatica leaves (CALEt) was orally 
administered at a dose of 300 mg/kg body weight (b. w). The activities of both mitochondrial and cytosolic enzymes viz succinate dehydrogenase 
(SDH), malate dehydrogenase (MDH), glutamate dehydrogenase (GDH), lactate dehydrogenase (LDH) and glucose 6 phosphate dehydrogenase 
(G6PDH) were measured in the liver and kidney of the experimental rats.  
Results: Diabetic rats showed a significant (p<0.001) reduction in the activities of mitochondrial enzymes such as SDH, MDH and GDH. 
Furthermore, the cytosolic enzyme G6PDH activity was significantly (p<0.001) decreased along with a significant increase in the LDH activity in 
diabetic rats. The daily oral treatment of CALEt to diabetic rats for 30 d reversed the above changes in a significant (p<0.001) manner.  
Conclusion: The results obtained in this study indicated that methanol extract of Centella asiatica leaves could restore the altered activities of 
mitochondrial and cytosolic enzymes, thereby suggesting its position in the energy production. Our data suggest that Centella asiatica leaves should 
be further explored for its role in the treatment of diabetes mellitus. 
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INTRODUCTION 
Diabetes mellitus is a well-known chronic disease caused by 
hereditary or acquired deficiency in the production of insulin by the 
pancreas or by the unutilization of the insulin produced and such 
deficiency results in increased concentrations of glucose in the 
blood, that damages many of the body's systems, particularly the 
blood vessels and the nerves. It is a leading cause of death and 
disability worldwide; its universal prevalence was about 8% in 2011 
and was predicted to increase to 10% by 2030 [1, 2]. Nearly 80% of 
people with diabetes live in low-and middle-income countries [3]. 
Mitochondria play a part in regulation of diverse physiological functions 
by providing energy for the majority of intracellular processes necessary 
for vital functions. Mitochondria are one of the key cell organelle in 
diabetes research because of its central role as a regulator of energy 
balance [4]. Magnetic resonance spectroscopy studies on human suggest 
that more subtle defects in mitochondrial function might take part in the 
pathogenesis of insulin resistance in diabetes, which is the most 
widespread metabolic disease in the world [5]. 
Mitochondrial function is usually required for normal glucose stimulated 
insulin release from pancreatic β cells. Albertoni et al. [6] reported that 
hyper glycemic condition had been connected with oxidative stress due 
to the altered mitochondrial metabolism. Reduced mitochondrial 
capacity in patients with type 2 diabetes was previously reported by 
Toledo et al. [7]. Recently, it has been reported that mitochondrial 
damage associated with β cell dysfunction is suspected to contribute to 
the development of diabetes [8]. TCA cycle plays an important role in 
diabetes mellitus because the activity of Kreb’s cycle enzymes acts as 
indicators of glucose utilization. Glucose-6-phosphate dehydrogenase 
(G6PDH) is present in the cytosol and is a key enzyme of a pentose 
phosphate pathway that provides energy to a number of cells (notably 
erythrocyte) and maintains the NADPH (Nicotinamide adenine 
dinucleotide phosphate) level [9]. It is important in preventing the 
complications of diabetes mellitus [10]. There is a massive 
understanding among cytosolic and mitochondrial enzymes to sustain 
the complimentary conditions to regulate various biological functions.  
Plants and herbs are mines of a huge number of bioactive phyto 
chemicals that might serve as lead for the expansion of effective, 
harmless and economical novel drugs [11]. Herbal formulation alone 
or in combination with oral hypoglycemic agents now and then 
produces good curative responses in some challenging cases where 
modern medicines alone have failed [12]. Centella asiatica is used in 
conventional and alternative treatment due to the broad range of 
pharmacological activities coupled with the secondary metabolites 
[13]. Traditionally, Centella asiatica was used for various diseases, 
including wound healing, bronchitis, asthma, diabetes, urethritis, liver 
complaints, allergy, cancer, diuretic, and hypertension also to improve 
mental ability [14]. Recently, we reported the anti-diabetic activity of 
Centella asiatica leaves in streptozotocin induced diabetic rats [15]. 
However, several aspects of the basic system of action of Centella 
asiatica still remain unclear up to now. This study was aimed to 
evaluate the effect of CALEt on SDH, MDH, GDH, G6PDH and LDH 
activities and also to find out whether the CALEt can control the 
physiological parameters and stabilize the altered Cori and TCA cycle 
in streptozotocin induced diabetic rats. 
MATERIALS AND METHODS 
Plant material 
Fresh leaves of Centella asiatica were collected from Talakona forest, 
Chittoor District, Andhra Pradesh, India during November 2009. The 
taxonomic identification of Centella asiatica (L) plant was confirmed 
by a senior Botanist, Mr. Madhava Chetty, Department of Botany, S. 
V. University, and a voucher specimen was deposited in the S. V. 
University herbarium, Tirupati, Andhra Pradesh, India. 
Animals 
Wistar strain male albino rats, aged 3 mo and weighing 160±20 g, 
were purchased from the authorized dealer (M/S Raghavendra 
Enterprises, Bangalore, India). The rats were housed in hygienic 
polypropylene cages having 6 rats per cage and maintained under 
temperature controlled room (25±2 °C) with a photo-period of 12 h 
lights and 12 h dark cycle, humidity 50 ± 10%. The rats were fed with 
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water and a standard rat pellet diet ad libitum (purchased from Sai 
Durga Agencies, Bangalore, India). The experiments were carried out 
according to the guidelines of the Committee for the Purpose of 
Control and Supervision on Experiments on Animals, Government of 
India (CPCSEA, 2003) and approved by the Institutional Animal Ethical 
Committee at Sri Venkateswara University, Tirupati, India (Resolution 
No. 10/(i)/a/CPCSEA/IACE/SVU/PSR-MRA/10.06. 2010). 
Chemicals 
All the chemicals used in the present study were Analytical Grade (AR) 
and were obtained from Sigma (St. Louis, MO, USA), Fisher (Pitrsburg, 
PA, USA), BDH Chemicals (England), Merck (Mumbai, India), Ranbaxy 
(New Delhi, India), and SISCO Research Laboratories (India). 
Plant extract preparation 
Fresh leaves of Centella asiatica were washed thoroughly, shade 
dried for 3 w and milled into the fine powder using a mechanical 
grinder. The powdered material (2 kg) was soaked in 6 L methanol 
for 48 h and filtered. The extracted material was filtered through 
whatman number 1(0.45 𝜇𝜇m Ref. HAWP04700, Bedford, MA, USA) 
filter paper. The above filtrate was collected and evaporated in a 
rotary evaporator (Rotavapor, R-210, Buchi Labortechnik, AG, 
Flawil, Switzerland) at 40-50 °C under reduced pressure. The yield 
(9.86 % w/w) was dried in vaccum desiccator and greenish 
material obtained was stored in the refrigerator at 4 °C until use. 
Induction of experimental diabetes mellitus 
The animals were fasted overnight, and diabetes was induced by a 
single intra-peritoneal injection of a freshly prepared 
streptozotocin (STZ) solution (50 mg/kg b. w [16, 17] dissolved in 
0.1 M cold citrate buffer, PH 4.5). After injection, rats had free 
access to food and water. The rats were allowed to drink 15% 
glucose solution for 72 h to counter hypoglycemic shock. The rats 
were considered as diabetic if their blood-glucose levels were 
more than 250 mg/dl on day 3 after STZ injection. The blood 
glucose levels were measured by using one touch-glucometer 
(Johnson & Johnson). After diabetes confirmation, rats were 
allowed for 7 d to acclimatize to diabetic condition, and rats with 
hyperglycemia (blood-glucose>250 mg/dl) were chosen for the 
study. Treatment was started on day 8 after STZ injection, which 
was also considered as the first day of treatment and continued 
further until end of the study period. 
Experimental design 
Grouping of animals 
Rats of the same age group (3 mo old) were divided into 5 groups, 
six rats in each group:  
Group I (Normal controls)-This group of rats received distilled 
water for equivalent handling. 
Group II (Normal rats treated with CALEt)-This group of rats 
received CALEt daily for a period of 30 d at a dose of 300 mg/kg b.w. 
Group III (Diabetic untreated rats)-In this group, diabetic rats are 
untreated for a period of 30 d, which served as diabetic controls. 
Group IV (Diabetic rats treated with CALEt)-After the diabetic 
confirmation test, this group of rats received CALEt for a period of 
30 d, at a dose of 300 mg/kg b.w. 
Group V (Diabetic rats treated with Glibenclamide)-In this group, 
diabetic rats were treated with the standard anti-diabetic drug, 
glibenclamide 5 mg/kg b. w [18] for the same period as in the group 
IV. This group was maintained for better comparison of the protective 
effect of Centella asiatica against diabetic induced complications.  
The dose of 300 mg/kg was selected based on the results of our 
previous study [15] where we found that 300 mg/kg b. w dose is the 
effective dose with perceptible useful effect or maximum dose 
beyond which no additional beneficial effect is seen. After 
completion of 30 d of treatment, the animals were sacrificed by 
cervical dislocation then the liver and kidney tissues were excised at 
4oC. The tissues were cleaned with ice-cold saline and immersed in 
liquid nitrogen. The tissues were stored immediately at-80oC for 
further biochemical analysis. 
Biochemical analysis 
Activities of selected mitochondrial enzymes, including SDH and 
MDH were assayed by the modified version of Nachlas et al. [19]. 
The GDH activity was assayed by the method of Lee and Lardy [20]. 
Cytosolic enzymes G6PDH activity was assayed by the method of 
Bergmayer, and Bruns [21] and LDH activity was assayed by the 
method of Prameelamma and Swami [22]. 
Statistical analysis 
The mean, standard deviation (SD) and probability test (Analysis of 
variance-ANOVA) were carried out according to Steel and Torrie [23] 
using BASIC programming techniques on SPSS PC for different 
parameters. The p-value of more than 0.05 was considered as not 
significant. 
RESULTS 
Table 1 and table 2 illustrate the effect of CALEt on the activities of SDH, 
MDH GDH, LDH and G6PDH in the liver and kidney of control and 
experimental rats. The mitochondrial enzyme (SDH, MDH GDH) 
activities were significantly (P<0.001) decreased in the diabetic control 
rats compared to the normal control rats. There were no significant 
changes in the activity of these enzymes in control rats treated with 
CALEt alone. Oral administration of CALEt to the diabetic rats 
significantly increased the enzyme activities compared with that of the 
diabetic untreated (control) rats. The enzymes in CALEt treated diabetic 
rats were similar with that of glibenclamide-induced augmentation. 
 
Table 1: Effect of CALEt on liver cytosolic & mitochondrial enzyme activities in the control and experimental group of rats after 30 d treatment 
Parameter/groups Group I Group II Group III Group IV Group V 
G-6-PDH(µ moles of formazan formed/mg protein/h) 5.24±0.14a 5.62±0.07b 2.75±0.11c 4.82±0.16d 4.46±0.07e 
LDH(µ moles of formazan formed/mg protein/h) 3.68±0.06a 3.42±0.09b 5.12±0.08c 4.21±0.13d 4.27±0.10d 
SDH(µ moles of formazan formed/mg protein/h) 8.95±0.09a 9.22±0.09b 5.11±0.07c 8.15±0.11d 7.35±0.14e 
MDH(µ moles of formazan formed/mg protein/h) 7.75±0.09a 8.22±0.07b 4.11±0.05c 7.45±0.11d 6.95±0.12e 
GDH(µ moles of formazan formed/mg protein/h) 8.37±0.15a 9.12±0.08b 5.77±0.08c 7.64±0.07d 7.19±0.05e 
Values are given as mean±SD of six individuals; Mean values that do not share same superscript differ significantly from each other at P<0.05 
 
Table 2: Effect of CALEt on kidney cytosolic & mitochondrial enzyme activities in the control and experimental group of rats after 30 d treatment 
Parameter/groups Group I Group II Group III Group IV Group V 
G-6-PDH(µ moles of formazan formed/mg protein/h) 3.71±0.17a 3.96±0.05b 2.43±0.13c 3.35±0.11d 3.22±0.09d 
LDH(µ moles of formazan formed/mg protein/h) 2.6±0.10a 2.4±0.12b 4.07±0.11c 3.01±0.09d 3.21±0.12e 
SDH(µ moles of formazan formed/mg protein/h) 6.69±0.03a 6.95±0.1b 4.3±0.15c 6.36±0.07d 5.87±0.07e 
MDH(µ moles of formazan formed/mg protein/h) 5.58±0.03a 5.85±0.1b 3.3±0.12c 5.31±0.02d 4.97±0.04e 
GDH(µ moles of formazan formed/mg protein/h) 6.64±0.11a 6.97±0.13b 4.79±0.12c 6.07±0.17d 5.77±0.11e 
Values are given as mean±S. D of six individuals; Mean values that do not share the same superscript differ significantly from each other at P<0.05 
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The cytosolic enzyme G6PDH activity was significantly (p<0.001) 
decreased along with the significant increase in the LDH activity in 
diabetic rats. Similar to the glibenclamide treatment, daily oral 
administration of CALEt to diabetic rats for 30 d reversed the altered 
G6PDH and LDH activities in a significant (p<0.001) manner. There 
were no significant changes in the activity of G6PDH and LDH in 
control rats treated with CALEt alone. 
DISCUSSION 
Streptozotocin (N-nitro derivative of glucosamine) is a naturally-
occurring broad spectrum antibiotic and cytotoxic chemical that is 
principally toxic to the pancreatic β cells in mammals [24]. Induction 
of observational diabetes in the rats by streptozotocin is very 
convenient and easy to use [25]. Streptozotocin injection leads to the 
degeneration of β cells of islets of langerhans [26]. It has been 
reported that in the rats, a dose ranging from 25 to 100 mg/kg b. w 
STZ injected intravenously was doing well in inducing a dose-
dependent hyperglycemia [24]. It is known that diabetic 
complications and increased oxidative stress are tissue-specific, 
moreover, accompanied via altered glucose transport, mitochondrial 
oxygen metabolism and energy production [27]. It was 
demonstrated that STZ inhibits the Krebs cycle and substantially 
decreases oxygen consumption by mitochondria [28, 29]. 
It is considerable evidence that diabetes is associated with tissue 
damage through oxidative stress [30], and that this extends to liver, 
skeletal muscle and heart tissues of STZ induced diabetic rodents 
[31, 32]. In the mitochondria of diabetic rats decreased oxygen 
utilization, and respiratory percentage was observed [33]. Similarly, 
decreased activities of citric acid cycle enzymes were observed by 
Sener et al. [34]. Recent metabolomic studies in models of type 1 
diabetes reported down regulation of key TCA cycle and 
mitochondrial proteins [35], and also enzyme activities’ [36].  
In the current study the activities of the mitochondrial marker 
enzymes SDH and MDH levels were significantly (P<0.001) dropped in 
the liver and kidney of STZ induced diabetic rats. Decreased SDH 
activity in diabetic condition affects succinate-fumarate conversion, 
which indicates depressed oxidative metabolism in mitochondria. 
Malate dehydrogenase plays an important role in the citric acid cycle 
by providing oxaloacetate for the formation of citrate with acetyl-CoA 
and further generates malate, which can nourish the cytosolic 
gluconeogenic pathway [37]. The decreased levels of MDH enzyme in 
diabetic rats suggest decreased utilization of malate. Decreased levels 
of SDH and MDH enzymes in diabetic rats were previously reported in 
several studies [38, 39]. The noticeable finding in this study is that the 
decreased SDH and MDH activities were ameliorated by CALEt 
treatment in diabetic rats. Increased SDH and MDH activities in CALEt 
treated diabetic rats indicate better utilization of energy yielding 
intermediates by the TCA cycle. In this study, improved mitochondrial 
marker enzymes in CALEt treated diabetic rats were similar with that 
of glibenclamide-induced augmentation. 
GDH is a mitochondrial matrix enzyme. It catalyzes the oxidative 
deamination of glutamate to α-ketoglutarate in a limited number of 
tissues in humans, including the liver, the kidney, the brain, and the 
pancreatic islets. In the pancreatic β cell, glucose stimulates insulin 
secretion by increasing the ATP:ADP ratio. An increased intracellular 
ATP and ADP ratio closes the ATP-sensitive potassium channel 
leading to the depolarization of cell membrane. On depolarization 
voltage gated calcium channels open, and increases the cytosolic 
calcium, which leads to release of insulin from stored granules. 
Amino acids stimulate insulin secretion through this pathway by 
increasing oxidation of glutamate through GDH because an essential 
amino acid abundant leucine is an allosteric activator of GDH 
enzyme activity [40]. In this study, the activity of GDH significantly 
decreased in the STZ induced diabetic rats. Ramudu et al. [41] and 
Rajeswar Reddy et al. [40] have reported the decreased GDH activity 
in the STZ induced diabetic rats. The decrease in GDH activity may 
be due to interference in energy metabolism, impairment of 
glutamate and activation of lipid peroxidation [42]. However, 
diabetic rats treated with CALEt for 30 d resulted in significant 
marked recovery of the GDH activity, which was almost similar with 
glibenclamide treatment. The increased activity might be due to 
synchronization of energy metabolism and elevation of glutamate in 
the cells by CALEt administration.  
Lactose Dehydrogenase (LDH) is a cytosolic enzyme and present in a 
wide variety of organisms. Usually when oxygen is deficient or in 
short supply LDH converts pyruvate to lactate and in the liver during 
the Cori cycle, it performs the reverse reaction [43]. According to 
Ainscow et al. [44] over-expression of LDH activity may be directly 
responsible for an insulin secretory defect in some forms of 
diabetes. Increased LDH activity in diabetic rats has also been 
reported by various researchers [45, 46]. Similarly, in this study an 
increase in the activity of LDH was observed in the diabetic rats. 
During diabetic condition, extreme accumulation of pyruvate may 
result in higher LDH activity. Excessive pyruvate is converted into 
lactate for which LDH is needed; therefore, the activity of LDH may 
be increased due to less insulin availability in diabetes [47]. 
However, diabetic rats treated with CALEt for 30 d resulted in 
significant marked recovery of LDH activity. The confined lactate 
dehydrogenase activity by CALEt was parallel with the antidiabetic 
drug glibenclamide treatment. 
The extra mitochondrial enzyme, G6PDH is a housekeeping enzyme 
that catalyzes the rate limiting step of the hexose monophosphate 
shunt (HMP). It converts glucose-6-phosphate to 6-phosphogluconate 
and generates the NADPH that is mandatory for the maintenance of 
reduced glutathione and reductive biosynthesis. G6PDH is the 
principle source of NADPH, which is of central importance to cellular 
redox regulation. The entire antioxidant system will be disturbed, if 
any change occurs in the G6PDH activity, which in turn alters NADPH 
levels, and makes tissues incredibly vulnerable to the oxidative 
damage [48]. In the present investigation, decreased G6PDH activity 
was noticed in the diabetic rats. Earlier, some of the investigators 
reported the reduced activity of G6PDH in type-2 diabetic individuals 
[49]. Similar to our findings, previous studies also demonstrated lower 
G6PDH activity in diabetic tissues [50, 51]. A decrease in the activity of 
glucose 6-phosphate dehydrogenase may equally slow down the 
pentose phosphate pathway in diabetic conditions [52]. The G6PDH 
activity was restored to normal level after treatment with CALEt for 30 
d. The restored G6PDH activity by CALEt treatment confirmed the 
protective role of CALEt against diabetes complications, since CALEt 
administration showed a similar upturn with standard anti-diabetic 
drug glibenclamide. 
CONCLUSION 
The results obtained in this research indicate that methanol extract 
of Centella asiatica leaves could be effective in preventing the 
diabetes induced disturbances in mitochondrial and cytosolic 
enzymes. This was shown by improved activities of the enzymes in 
diabetic rats. However, further pharmacological and biochemical 
investigations are considered necessary to find out the active 
constituent and its system of action to understand the bioactive and 
ameliorative potential of the plant. 
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